drug

donanemab

1 story · latest Sep 25, 2026

Status: Investigational
Code: LY3002813
Trials: 6 registered trials in coverage

Relationships

Developed by Eli Lilly

Timeline

Loxo posts Phase 3 pirtobrutinib results; five more Lilly-linked trials update

Sep 25Weekly roundup, 6 itemsabemaciclib brenipatide

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.